Drug Shortage Report for RILUTEK

Last updated on 2020-08-18 History
Report ID 98763
Drug Identification Number 02242763
Brand name RILUTEK
Common or Proper name Rilutek
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) RILUZOLE
Strength(s) 50MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 60
ATC code N07XX
ATC description OTHER NERVOUS SYSTEM DRUGS
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2019-12-16
Actual start date
Estimated end date 2021-06-30
Actual end date
Shortage status Actual shortage
Updated date 2020-08-18
Company comments The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-08-18 French Compare
v6 2020-08-18 English Compare
v5 2019-12-17 English Compare
v4 2019-11-21 French Compare
v3 2019-11-21 English Compare
v2 2019-11-14 French Compare
v1 2019-11-14 English Compare